Physician profile
James Black
NPI 1821000191
$2,199.89
in general payments reported to CMS, 2019-2025
8 companies · $886 in 2025
The $886 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $206 · 2021: $693 · 2022: $209 · 2023: $206 · 2025: $886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $772 · Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $771.74 |
| Food and Beverage | $319.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $794.79 | 2020-2022 | |
| Integra Lifesciences Corporation | $771.74 | 2025 | Cytal, Micromatrix |
| Tela Bio, INC. | $169.37 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $158.60 | 2020-2022 | |
| Stryker Corporation | $131.57 | 2021 | |
| W. L. Gore & Associates, INC. | $114.06 | 2025 | Gore Excluder Aaa Endoprosthesis |
| Mentor Worldwide LLC | $36.14 | 2023 | Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Biotissue Holdings INC. | $23.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.